Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2011, 12(6), 3740-3756; doi:10.3390/ijms12063740
Article

Sulfotyrosine Recognition as Marker for Druggable Sites in the Extracellular Space

1
, 1
, 2
, 1
 and 1,*
Received: 14 March 2011; in revised form: 16 May 2011 / Accepted: 23 May 2011 / Published: 8 June 2011
(This article belongs to the Special Issue A Systematic Development Method for Rational Drug Design)
View Full-Text   |   Download PDF [787 KB, updated 19 June 2014; original version uploaded 19 June 2014]   |   Browse Figures
Abstract: Chemokine signaling is a well-known agent of autoimmune disease, HIV infection, and cancer. Drug discovery efforts for these signaling molecules have focused on developing inhibitors targeting their associated G protein-coupled receptors. Recently, we used a structure-based approach directed at the sulfotyrosine-binding pocket of the chemokine CXCL12, and thereby demonstrated that small molecule inhibitors acting upon the chemokine ligand form an alternative therapeutic avenue. Although the 50 members of the chemokine family share varying degrees of sequence homology (some as little as 20%), all members retain the canonical chemokine fold. Here we show that an equivalent sulfotyrosine-binding pocket appears to be conserved across the chemokine superfamily. We monitored sulfotyrosine binding to four representative chemokines by NMR. The results suggest that most chemokines harbor a sulfotyrosine recognition site analogous to the cleft on CXCL12 that binds sulfotyrosine 21 of the receptor CXCR4. Rational drug discovery efforts targeting these sites may be useful in the development of specific as well as broad-spectrum chemokine inhibitors.
Keywords: chemokine; sulfotyrosine, NMR; structure; alignment; drug discovery chemokine; sulfotyrosine, NMR; structure; alignment; drug discovery
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Ziarek, J.J.; Heroux, M.S.; Veldkamp, C.T.; Peterson, F.C.; Volkman, B.F. Sulfotyrosine Recognition as Marker for Druggable Sites in the Extracellular Space. Int. J. Mol. Sci. 2011, 12, 3740-3756.

AMA Style

Ziarek JJ, Heroux MS, Veldkamp CT, Peterson FC, Volkman BF. Sulfotyrosine Recognition as Marker for Druggable Sites in the Extracellular Space. International Journal of Molecular Sciences. 2011; 12(6):3740-3756.

Chicago/Turabian Style

Ziarek, Joshua J.; Heroux, Maxime S.; Veldkamp, Christopher T.; Peterson, Francis C.; Volkman, Brian F. 2011. "Sulfotyrosine Recognition as Marker for Druggable Sites in the Extracellular Space." Int. J. Mol. Sci. 12, no. 6: 3740-3756.



Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert